Placebo - Capsule

DRUG4 trials

Sponsors

Eli Lilly and Company, Medical University of South Carolina

Conditions

Diabetes Mellitus, Type 2HealthyLymphangioleiomyomatosisSleep Initiation and Maintenance Disorders

Phase 1

A Study of LY2624803 in Japanese Participants With Transient Insomnia

CompletedNCT01784614

Eli Lilly and CompanySleep Initiation and Maintenance Disorders

Start: 2009-09-30End: 2010-03-31Updated: 2016-01-28

A Study of LY3108743 in Healthy Participants and Participants With Type 2 Diabetes

CompletedNCT01995656

Eli Lilly and CompanyDiabetes Mellitus, Type 2

Start: 2013-12-31End: 2014-04-30Target: 44Updated: 2014-07-15

LAM Pilot Study With Imatinib Mesylate

CompletedNCT03131999

Medical University of South CarolinaLymphangioleiomyomatosis

Start: 2018-01-23End: 2019-03-07Updated: 2020-06-16

A Study of LY3154885 in Healthy Participants

TerminatedNCT04014361

Eli Lilly and CompanyHealthy

Start: 2019-08-09End: 2020-02-09Updated: 2024-03-12